Open AccessStrategies for Implementation Research to Investigate the Negative Pharmacokinetic Interaction Between Efavirenz and Dolutegravir
Author(s) -
Gene D. Morse
Publication year - 2020
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciaa982
Subject(s) - dolutegravir , efavirenz , pharmacokinetics , cyp2b6 , dosing , rilpivirine , medicine , regimen , pharmacology , virology , oncology , viral load , human immunodeficiency virus (hiv) , antiretroviral therapy , cyp3a4 , cytochrome p450 , metabolism
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom